中国麻风皮肤病杂志 ›› 2019, Vol. 35 ›› Issue (8): 500-504.doi: 10.12144/zgmfskin201908500

• 综述 • 上一篇    下一篇

结节性痒疹治疗进展

张寒梅  冯素英   

  1. 中国医学科学院北京协和医学院皮肤病医院皮肤科江苏省皮肤病与性病学重点实验室，江苏南京，210042
  • 出版日期:2019-08-15 发布日期:2019-08-19
  • 通讯作者: 冯素英，E-mail: fengsy@pumcderm.cams.cn

Update in the treatment of prurigo nodularis

ZHANG Hanmei, FENG Suying   

  1. Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Institute of Dermatology, Department of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China
  • Online:2019-08-15 Published:2019-08-19
  • Contact: FENG Suying, E-mail: fengsy@pumcderm.cams.cn

PDF (PC)

222

摘要： 结节性痒疹的治疗主要包括局部治疗、光疗和系统治疗，近年来出现了一些新的治疗方法，如神经激肽-1受体（NK-1R）拮抗剂、白介素-31受体（IL-31R）拮抗剂、Dupilumab和μ-阿片受体拮抗剂/κ-阿片受体激动剂等。本文対结节性痒疹的治疗进展进行综述。

关键词: 结节性痒疹, 治疗

Abstract: The treatment of prurigo nodularis (PN) includes topical therapy, phototherapy and systemic therapy. Some new treatments  have been tried, such as neurokinin-1 receptor (NK-1R) antagonists, interleukin-31 receptor (IL-31R) antagonists, Dupilumab, μ-opioid receptor antagonists/κ-opioid receptor agonists and so on. The update of these new treatments of prurigo nodularis is reviewed in this paper.

Key words: prurigo nodularis, treatment